Review: taking Zonegran and Vyvanse together


Summary

Drug interactions are reported among people who take Zonegran and Vyvanse together. This review analyzes the effectiveness and drug interactions between Zonegran and Vyvanse. It is created by eHealthMe based on reports of 12 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Zonegran and Vyvanse >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Zonegran

Zonegran has active ingredients of zonisamide. It is often used in epilepsy. (latest outcomes from Zonegran 3,204 users)

Vyvanse

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Vyvanse 8,615 users)

On Aug, 23, 2016

12 people who take Zonegran, Vyvanse are studied.


Number of reports submitted per year:

Zonegran and Vyvanse drug interactions.

Drug effectiveness over time:

Zonegran:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Vyvanse:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Zonegran:
  • female: 33.0% - (1 of 3 people)
  • male: 0.0% - (0 of 0 people)
Vyvanse:
  • female: 100.0% - (3 of 3 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Zonegran:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Vyvanse:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (1 of 1 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • pruritus
  • vaginal haemorrhage
  • drug ineffective
  • formication
  • placenta praevia
1 - 2 years:
  • constipation
  • high blood pressure
2 - 5 years:
  • drug ineffective
  • placenta praevia
  • vaginal haemorrhage
5 - 10 years:
  • constipation
  • high blood pressure
not specified:
  • migraine
  • asthenia
  • eye irritation
  • eye pain
  • headache
  • abdominal discomfort
  • abnormal behaviour
  • blindness unilateral
  • blood thyroid stimulating hormone increased
  • crying

Most common drug interactions by gender *:

female:
  • headache
  • placenta praevia
  • vaginal haemorrhage
  • abdominal discomfort
  • blindness unilateral
  • migraine
  • asthenia
  • drug ineffective
  • eye irritation
  • eye pain
male:
  • abnormal behaviour
  • emotional distress
  • formication
  • hostility
  • pruritus

Most common drug interactions by age *:

10-19:
  • abdominal discomfort
  • abnormal behaviour
  • asthenia
  • blindness unilateral
  • ear infection
  • emotional distress
  • eye infection
  • eye irritation
  • eye pain
  • formication
40-49:
  • constipation
  • high blood pressure
50-59:
  • gait disturbance
  • headache
  • infusion related reaction
  • injection site atrophy
  • asthenia
  • blood thyroid stimulating hormone increased
  • crying
  • dyspnoea
  • eye irritation
  • eye pain
60+:
  • migraine

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Zonegran and Vyvanse?


Recent conversations of related support groups:

Can you answer these questions?

More questions for: Zonegran, Vyvanse

You may be interested in these reviews

More reviews for: Zonegran, Vyvanse

On eHealthMe, Zonegran (zonisamide) is often used to treat epilepsy. Vyvanse (lisdexamfetamine dimesylate) is often used to treat attention deficit hyperactivity disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.